The Development of Regenerative Medicine in Russia and in the World: Leading Researchers and Technological Drivers

Развитие регенеративной медицины в России и в мире: исследователи-лидеры и технологические драйверы

Kanev, Alexander (Канев, Александр) (), Kurakov, Fedor (Кураков, Федор) (), Cherchenko, Olga (Черченко, Ольга) () and Tsvetkova, Liliya (Цветкова, Лилия) ()
Additional contact information
Kanev, Alexander (Канев, Александр): Central Research Institute of Organization and Informatization of Healthcare of the Ministry of Health of Russia
Kurakov, Fedor (Кураков, Федор): Russian Presidential Academy of National Economy and Public Administration
Cherchenko, Olga (Черченко, Ольга): Central Research Institute of Organization and Informatization of Healthcare of the Ministry of Health of Russia
Tsvetkova, Liliya (Цветкова, Лилия): Central Research Institute of Organization and Informatization of Healthcare of the Ministry of Health of Russia

Economy of science, 2022, vol. 8, 202-219

Abstract: An assessment was made of the current level of development of the thematic area of “regenerative medicine” in Russia and in the world based on an analysis of the list of methods of cell, gene therapy and tissue engineering officially approved by the regulatory authorities of the world as of November 2022, as well as an analysis of the global publication and patent portfolio. It is shown that the practical result of the 20-year development of regenerative medicine was the creation and approval of 70 products and technologies, of which 12 are methods (products) of cellular immunotherapy, 11 are gene therapy products, 17 are cell therapy products, 8 are cord blood therapy methods., 22 – products of tissue engineering. The United States is the leader in terms of the number of regenerative medicine technologies and products approved by regulatory authorities for the use of technologies and products in healthcare practice – 32 methods and products, the second position is occupied by the EU (21), followed by the Republic of Korea (16), Japan (10), Canada (7). 3 technologies and products were approved in India, China and Australia, 2 in Singapore, 1 in New Zealand. During the observation period, only one gene therapy product was recalled (ZYNTEGLO in the EU in 2021) The country that makes the most significant contribution to research and development in the field of regenerative medicine is the United States, which has a national publication portfolio that is at least three times larger than the top 5 countries in this topic area (China, Japan, UK and Italy). The Russian Federation ranks 17th with the total number of publications in the national portfolio. The performed scientometric analysis made it possible to identify the most developed scientific areas in the Russian Federation related to the field of regenerative medicine.

Keywords: regenerative medicine; technologies; products; regulators; applications; scientometric analysis; patent analytics (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://repec.ranepa.ru/rnp/ecosci/es2215.pdf

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:rnp:ecosci:es2215

Access Statistics for this article

Economy of science is currently edited by Natalia Kurakova

More articles in Economy of science from Russian Presidential Academy of National Economy and Public Administration Contact information at EDIRC.
Bibliographic data for series maintained by RANEPA maintainer ().